|
1
|
Stupp R, Mason WP, van den Bent MJ, Weller
M, Fisher B, Taphoorn MJ, Belanger K, Brandes AA, Marosi C, Bogdahn
U, et al: Radiotherapy plus concomitant and adjuvant temozolomide
for glioblastoma. N Engl J Med. 352:987–996. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Wu DG, Wang YY, Fan LG, Luo H, Han B, Sun
LH, Wang XF, Zhang JX, Cao L, Wang XR, et al: MicroRNA-7 regulates
glioblastoma cell invasion via targeting focal adhesion kinase
expression. Chin Med J (Engl). 124:2616–2621. 2011.PubMed/NCBI
|
|
3
|
Heidebrecht HJ, Buck F, Steinmann J,
Sprenger R, Wacker HH and Parwaresch R: p100: A novel
proliferation-associated nuclear protein specifically restricted to
cell cycle phases S, G2, and M. Blood. 90:226–233. 1997.PubMed/NCBI
|
|
4
|
Kufer TA, Silljé HH, Körner R, Gruss OJ,
Meraldi P and Nigg EA: Human TPX2 is required for targeting
Aurora-A kinase to the spindle. J Cell Biol. 158:617–623. 2002.
View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Gruss OJ, Wittmann M, Yokoyama H,
Pepperkok R, Kufer T, Silljé H, Karsenti E, Mattaj IW and Vernos I:
Chromosome-induced microtubule assembly mediated by TPX2 is
required for spindle formation in HeLa cells. Nat Cell Biol.
4:871–879. 2002. View
Article : Google Scholar : PubMed/NCBI
|
|
6
|
Li Y, Tang H, Sun Z, Bungum AO, Edell ES,
Lingle WL, Stoddard SM, Zhang M, Jen J, Yang P and Wang L:
Network-based approach identified cell cycle genes as predictor of
overall survival in lung adenocarcinoma patients. Lung Cancer.
80:91–98. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Scotto L, Narayan G, Nandula SV,
Arias-Pulido H, Subramaniyam S, Schneider A, Kaufmann AM, Wright
JD, Pothuri B, Mansukhani M and Murty VV: Identification of copy
number gain and overexpressed genes on chromosome arm 20q by an
integrative genomic approach in cervical cancer: Potential role in
progression. Genes Chromosomes Cancer. 47:755–765. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Yan L, Li S, Xu C, Zhao X, Hao B, Li H and
Qiao B: Target protein for Xklp2 (TPX2), a microtubule-related
protein, contributes to malignant phenotype in bladder carcinoma.
Tumour Biol. 34:4089–4100. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Li B, Qi XQ, Chen X, Huang X, Liu GY, Chen
HR, Huang CG, Luo C and Lu YC: Expression of targeting protein for
Xenopus kinesin-like protein 2 is associated with progression of
human malignant astrocytoma. Brain Res. 1352:200–207. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Gao J, Ding F, Liu Q and Yao Y: Knockdown
of MACC1 expression suppressed hepatocellular carcinoma cell
migration and invasion and inhibited expression of MMP-2 and MMP-9.
Mol Cell Biochem. 376:21–32. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Wang YH, Dong YY, Wang WM, Xie XY, Wang
ZM, Chen RX, Chen J, Gao DM, Cui JF and Ren ZG: Vascular
endothelial cells facilitated HCC invasion and metastasis through
the Akt and NF-κB pathways induced by paracrine cytokines. J Exp
Clin Cancer Res. 32:512013. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Liu Q, Yang P, Tu K, Zhang H, Zheng X, Yao
Y and Liu Q: TPX2 knockdown suppressed hepatocellular carcinoma
cell invasion via inactivating AKT signaling and inhibiting MMP-2
and MMP-9 expression. Chin J Cancer Res. 26:410–417.
2014.PubMed/NCBI
|
|
13
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(−Delta Delta C(T)) Method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Vivanco I and Sawyers CL: The
phosphatidylinositol 3-kinase AKT pathway in human cancer. Nat Rev
Cancer. 2:489–501. 2002. View
Article : Google Scholar : PubMed/NCBI
|
|
15
|
Clarke J, Butowski N and Chang S: Recent
advances in therapy for glioblastoma. Arch Neurol. 67:279–283.
2010. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Liu R, Page M, Solheim K, Fox S and Chang
SM: Quality of life in adults with brain tumors: Current knowledge
and future directions. Neuro Oncol. 11:330–339. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Neumayer G, Belzil C, Gruss OJ and Nguyen
MD: TPX2: Of spindle assembly, DNA damage response, and cancer.
Cell Mol Life Sci. 71:3027–3047. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Chang H, Wang J, Tian Y, Xu J, Gou X and
Cheng J: The TPX2 gene is a promising diagnostic and therapeutic
target for cervical cancer. Oncol Rep. 27:1353–1359.
2012.PubMed/NCBI
|
|
19
|
Choe G, Horvath S, Cloughesy TF, Crosby K,
Seligson D, Palotie A, Inge L, Smith BL, Sawyers CL and Mischel PS:
Analysis of the phosphatidylinositol3′-kinase signaling pathway in
glioma patients in vivo. Cancer Res. 63:2742–2746. 2003.PubMed/NCBI
|
|
20
|
Haas-Kogan D, Shalev N, Wong M, Mills G,
Yount G and Stokoe D: Protein kinase B (PKB/Akt) activity is
elevated in glioma cells due to mutation of the tumor suppressor
PTEN/MMAC. Curr Biol. 8:1195–1198. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Robinson GL, Robinson JP, Lastwika KJ,
Holmen SL and Vanbrocklin MW: Akt signaling accelerates tumor
recurrence following ras inhibitionin the context of ink4a/arf
loss. Genes Cancer. 4:476–485. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Diehl JA, Cheng M, Roussel MF and Sherr
CJ: Glycogen synthase kinase-3beta regulates cyclin D1 proteolysis
and subcellular localization. Genes Dev. 12:3499–3511. 1998.
View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Cross DA, Alessi DR, Cohen P, Andjelkovich
M and Hemmings BA: Inhibition of glycogen synthase kinase-3 by
insulin mediated by protein kinase B. Nature. 378:785–789. 1995.
View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Lee J and Kim SS: The function of p27 KIP1
during tumor development. Exp Mol Med. 41:765–771. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Child ES and Mann DJ: The intricacies of
p21 phosphorylation: Protein/protein interactions, subcellular
localization and stability. Cell Cycle. 5:1313–1319. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Cawston TE and Wilson AJ: Understanding
the role of tissue degrading enzymes and their inhibitors in
development and disease. Best Pract Res Clin Rheumatol.
20:983–1002. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Fu Y, Zhang Q, Kang C, Zhang J, Zhang K,
Pu P, Wang G and Wang T: Inhibitory effects of adenovirus mediated
Akt1 and PIK3R1 shRNA on the growth of malignant tumor cells in
vitro and in vivo. Cancer Biol Ther. 8:1002–1009. 2009. View Article : Google Scholar : PubMed/NCBI
|
